Meeting
2018 Gastrointestinal Cancers Symposium
Clinical significance of monitoring KRAS in tissue and serum of pancreatic cancer patients.
Authors
Fumiaki Watanabe
Jichi Medical University, Saitama, Japan
Fumiaki Watanabe , Koichi Suzuki , Hideki Ishikawa , Yuhei Endo , Kosuke Ichida , Yuji Takayama , Taro Fukui , Nao Kakizawa , Naoya Kasahara , Takaharu Kato , Hiroshi Noda , Toshiki Rikiyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 286)
DOI
10.1200/JCO.2018.36.4_suppl.286
Abstract #
286
Poster Bd #
D19
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
The clinical significance of KRAS monitoring in tumor tissues and blood of patients with pancreatic tumor.
First Author: Fumiaki Watanabe
Poster
2020 Gastrointestinal Cancers Symposium
Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients.
First Author: Fumiaki Watanabe
Poster
2016 Gastrointestinal Cancers Symposium
Liquid biopsy leads to a paradigm shift in cancer treatment.
First Author: Koichi Suzuki
Poster
2015 Gastrointestinal Cancers Symposium
Comparative circulating tumor DNA levels for KRAS mutations in patients with nonresectable pancreatic cancer.
First Author: Julia S. Johansen